In what they’re touting as their entry point into US cannabis when it’s federally legal, Tilray announced it has acquired a “majority position” in retailer MedMen in a creative deal that CEO Irwin Simon said could lead to a future acquisition.
CNBC’s Squawk on the Street celebrated 4/20 with Aphria CEO Irwin Simon to talk about the delayed deal with Tilray, opportunities in the European market and more.
Some of Canada’s largest cannabis companies are losing market share after a tough year, according to data analyzed by ATB Capital Markets.
FOLLOWING its recent purchase of UK cannabis firm EMMAC Life Sciences, Curaleaf has now secured an additional $130m from a single institutional investor to fund its European ambitions.
There was a lot of hype around Aphria’s planned merger with Tilray.
On this episode of BofC Live, we connect with Bernie Yeung, Senior Vice President, Sales & Marketing at Aphria Inc.
Not too big, not too small New Cannabis Ventures, the investor insights and information portal run by Alan Brochstein, has been tracking cannabis public companies since before Day 1.
The BackgroundJust a few days after cannabis giants Aphria and Tilray launched a website for shareholders to keep tabs on their intention to join forces and create the world’s largest cannabis company, Marijuana Business Daily’s Matt Lamers pored through filings to the U.S.
Expect more deals as business look for more ways to grow by Diane Peters Volume 1: Issue 17 It was the deal heard around the cannabis world: On December 16, Tilray Inc. and Aphria Inc. joined forces to create the world’s largest cannabis business.
